×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PVCT – provectus biopharms (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PVCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
09:17 am
pvct
Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology [Yahoo! Finance]
Low
Report
Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology [Yahoo! Finance]
12/11
09:00 am
pvct
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
Medium
Report
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
12/10
07:47 am
pvct
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections [Yahoo! Finance]
High
Report
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections [Yahoo! Finance]
12/10
07:30 am
pvct
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
High
Report
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
10/24
08:00 am
pvct
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
Low
Report
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
10/10
08:00 am
pvct
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
Medium
Report
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
09:00 am
pvct
Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 05
Medium
Report
Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 05
12/6
07:46 pm
pvct
Form SC 13D/A PROVECTUS BIOPHARMACEUTI Filed by: Pershing Edward
Medium
Report
Form SC 13D/A PROVECTUS BIOPHARMACEUTI Filed by: Pershing Edward
12/5
06:01 am
pvct
Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 02
High
Report
Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 02
12/4
09:53 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Bailey Webster
High
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Bailey Webster
12/4
09:50 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Lacey John III
High
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Lacey John III
12/4
09:44 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: WACHTER ERIC PHD
High
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: WACHTER ERIC PHD
12/4
09:24 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Raines Heather
High
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Raines Heather
12/4
07:53 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Rodrigues Dominic
High
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Dec 02 Filed by: Rodrigues Dominic
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: